Chromatin assembly factor 1 suppresses epigenetic reprogramming toward adaptive drug resistance

Hata, 2016, Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition, Nat Med, 22, 262, 10.1038/nm.4040 Hugo, 2015, Non-genomic and immune evolution of melanoma acquiring MAPKi resistance, Cell, 162, 1271, 10.1016/j.cell.2015.07.061 Thress, 2015, Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M, Nat Med, 21, 560, 10.1038/nm.3854 Nazarian, 2010, Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation, Nature, 468, 973, 10.1038/nature09626 Mu, 2017, SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer, Science, 355, 84, 10.1126/science.aah4307 Sun, 2014, Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma, Nature, 508, 118, 10.1038/nature13121 Toska, 2017, PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D, Science, 355, 1324, 10.1126/science.aah6893 Fallahi-Sichani, 2017, Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly dividing de-differentiated state, Mol Syst Biol, 13, 905, 10.15252/msb.20166796 Rambow, 2018, Toward minimal residual disease-directed therapy in melanoma, Cell, 174, 843, 10.1016/j.cell.2018.06.025 Sharma, 2010, A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations, Cell, 141, 69, 10.1016/j.cell.2010.02.027 Flavahan, 2017, Epigenetic plasticity and the hallmarks of cancer, Science, 357, 10.1126/science.aal2380 Yadav, 2018, Chromatin plasticity: a versatile landscape that underlies cell fate and identity, Science, 361, 1332, 10.1126/science.aat8950 Serra-Cardona, 2018, Replication-coupled nucleosome assembly in the passage of epigenetic information and cell identity, Trends Biochem Sci, 43, 136, 10.1016/j.tibs.2017.12.003 Cheloufi, 2015, The histone chaperone CAF-1 safeguards somatic cell identity, Nature, 528, 218, 10.1038/nature15749 Ishiuchi, 2015, Early embryonic-like cells are induced by down regulating replication-dependent chromatin assembly, Nat Struct Mol Biol, 22, 662, 10.1038/nsmb.3066 Ng, 2019, The histone chaperone CAF-1 cooperates with the DNA methyltransferases to maintain Cd4 silencing in cytotoxic T cells, Genes Dev, 33, 669, 10.1101/gad.322024.118 Banaszynski, 2013, Hira-dependent histone H3.3 deposition facilitates PRC2 recruitment at developmental loci in ES cells, Cell, 155, 107, 10.1016/j.cell.2013.08.061 Gonzalez-Munoz, 2014, Cell reprogramming. Histone chaperone ASF1A is required for maintenance of pluripotency and cellular reprogramming, Science, 345, 822, 10.1126/science.1254745 2019, CHAF1B suppresses myeloid differentiation to promote Leukemogenesis, Cancer Discov, 9, 11, 10.1158/2159-8290.CD-RW2018-207 Volk, 2018, A CHAF1B-dependent molecular switch in hematopoiesis and leukemia pathogenesis, Cancer Cell, 34, 707, 10.1016/j.ccell.2018.10.004 Wang, 2018, An acquired vulnerability of drug-resistant melanoma with therapeutic potential, Cell, 173, 1413, 10.1016/j.cell.2018.04.012 Dibb, 2004, Switching on kinases: oncogenic activation of BRAF and the PDGFR family, Nat Rev Cancer, 4, 718, 10.1038/nrc1434 Shi, 2011, Combinatorial treatments that overcome PDGFRbeta-driven resistance of melanoma cells to V600EB-RAF inhibition, Cancer Res, 71, 5067, 10.1158/0008-5472.CAN-11-0140 Hirata, 2015, Intravital imaging reveals how BRAF inhibition generates drug-tolerant microenvironments with high integrin beta1/FAK signaling, Cancer Cell, 27, 574, 10.1016/j.ccell.2015.03.008 Villanueva, 2010, Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K, Cancer Cell, 18, 683, 10.1016/j.ccr.2010.11.023 Ramsdale, 2015, The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma, Sci Signal, 8, ra82, 10.1126/scisignal.aab1111 Zuber, 2011, RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia, Nature, 478, 524, 10.1038/nature10334 Zhang, 2017, RPA interacts with HIRA and regulates H3.3 deposition at gene regulatory elements in mammalian cells, Mol Cell, 65, 272, 10.1016/j.molcel.2016.11.030 Quivy, 2008, The HP1-p150/CAF-1 interaction is required for pericentric heterochromatin replication and S-phase progression in mouse cells, Nat Struct Mol Biol, 15, 972, 10.1038/nsmb.1470 Houlard, 2006, CAF-1 is essential for heterochromatin organization in pluripotent embryonic cells, PLoS Genet, 2, e181, 10.1371/journal.pgen.0020181 Huang, 2010, Drosophila CAF-1 regulates HP1-mediated epigenetic silencing and pericentric heterochromatin stability, J Cell Sci, 123, 2853, 10.1242/jcs.063610 Burgess, 2013, Histone chaperones in nucleosome assembly and human disease, Nat Struct Mol Biol, 20, 14, 10.1038/nsmb.2461 Loyola, 2009, The HP1alpha-CAF1-SetDB1-containing complex provides H3K9me1 for Suv39-mediated K9me3 in pericentric heterochromatin, EMBO Rep, 10, 769, 10.1038/embor.2009.90 Long, 2014, Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma, Nat Commun, 5, 5694, 10.1038/ncomms6694 Rizos, 2014, BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impact, Clin Cancer Res, 20, 1965, 10.1158/1078-0432.CCR-13-3122 Hoek, 2003, Chromatin assembly factor 1 is essential and couples chromatin assembly to DNA replication in vivo, Proc Natl Acad Sci U S A, 100, 12183, 10.1073/pnas.1635158100 Ye, 2003, Defective S phase chromatin assembly causes DNA damage, activation of the S phase checkpoint, and S phase arrest, Mol Cell, 11, 341, 10.1016/S1097-2765(03)00037-6 Moldovan, 2007, PCNA, the maestro of the replication fork, Cell, 129, 665, 10.1016/j.cell.2007.05.003 Zou, 2006, Functions of human replication protein A (RPA): from DNA replication to DNA damage and stress responses, J Cell Physiol, 208, 267, 10.1002/jcp.20622 Rolef Ben-Shahar, 2009, Two fundamentally distinct PCNA interaction peptides contribute to chromatin assembly factor 1 function, Mol Cell Biol, 29, 6353, 10.1128/MCB.01051-09 Hwang, 2018, Chk1 inhibition as a novel therapeutic strategy in melanoma, Oncotarget, 9, 30450, 10.18632/oncotarget.25765 Sears, 1999, Ras enhances Myc protein stability, Mol Cell, 3, 169, 10.1016/S1097-2765(00)80308-1 Sears, 2000, Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability, Genes Dev, 14, 2501, 10.1101/gad.836800 Konermann, 2015, Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex, Nature, 517, 583, 10.1038/nature14136 Wang, 2013, A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth, Nat Commun, 4, 2035, 10.1038/ncomms3035 Hashizume, 2014, Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma, Nat Med, 20, 1394, 10.1038/nm.3716 Holohan, 2013, Cancer drug resistance: an evolving paradigm, Nat Rev Cancer, 13, 714, 10.1038/nrc3599 Becker, 2016, H3K9me3-dependent heterochromatin: barrier to cell fate changes, Trends Genet, 32, 29, 10.1016/j.tig.2015.11.001 Matoba, 2014, Embryonic development following somatic cell nuclear transfer impeded by persisting histone methylation, Cell, 159, 884, 10.1016/j.cell.2014.09.055 Chen, 2013, H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs, Nat Genet, 45, 34, 10.1038/ng.2491 McDonald, 2017, Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis, Nat Genet, 49, 367, 10.1038/ng.3753 Hess, 2004, AP-1 subunits: quarrel and harmony among siblings, J Cell Sci, 117, 5965, 10.1242/jcs.01589 Yang, 2015, Systematic identification of factors for provirus silencing in embryonic stem cells, Cell, 163, 230, 10.1016/j.cell.2015.08.037 Sanchez-Danes, 2018, A slow-cycling LGR5 tumour population mediates basal cell carcinoma relapse after therapy, Nature, 562, 434, 10.1038/s41586-018-0603-3 Delmore, 2011, BET bromodomain inhibition as a therapeutic strategy to target c-Myc, Cell, 146, 904, 10.1016/j.cell.2011.08.017 Zawistowski, 2017, Enhancer remodeling during adaptive bypass to MEK inhibition is attenuated by pharmacologic targeting of the P-TEFb complex, Cancer Discov, 7, 302, 10.1158/2159-8290.CD-16-0653 Chou, 2010, EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF, Cancer Res, 70, 8822, 10.1158/0008-5472.CAN-10-0638 Pulikkan, 2018, CBFbeta-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia, Cell, 174, 172, 10.1016/j.cell.2018.05.048